文献速递乳腺MR

乳腺扩散加权成像中表观扩散系数随扩散时间的变化率取决于肿瘤类型和分子预后标志物表达

The Rate of Apparent Diffusion Coefficient Change With Diffusion Time on Breast Diffusion-Weighted Imaging Depends on Breast Tumor Types and Molecular Prognostic Biomarker Expression.
PubMed 文献 · Invest Radiol · 2021-01-01

前瞻性纳入201例已知或疑似乳腺肿瘤患者,分析132个肿瘤(86恶性、46良性),在3T磁共振上用振荡和脉冲扩散编码梯度(有效扩散时间4.7和96.6毫秒)及b值0和700 s/mm²行双扩散时间DWI。恶性肿瘤ADC值更低、ΔADC更高;各扩散时间ADC及ΔADC鉴别良恶性的特异度(87.0%-95.7%)优于BI-RADS(73.9%),但敏感度(87.2%-90.7%)低于BI-RADS(100%)。ADC值与激素受体表达相关,Ki-67阳性癌ΔADC大于Ki-67阴性癌。

要点

  • 恶性肿瘤ADC值低于良性肿瘤,ΔADC高于良性肿瘤。
  • ADC及ΔADC鉴别良恶性特异度87.0%-95.7%优于BI-RADS的73.9%,敏感度87.2%-90.7%低于BI-RADS的100%。
  • Ki-67阳性癌ΔADC大于Ki-67阴性癌(FDR校正P=0.018),扩散时间应报告。

关键影像表现/征象

  • 恶性肿瘤ADC值低于良性肿瘤,ΔADC高于良性肿瘤。
  • ER阳性癌ADCshort和ADC0-1000低于ER阴性癌(FDR校正P=0.037和0.018)。
  • PR阳性癌ADCshort、ADClong和ADC0-1000低于PR阴性癌(FDR校正P=0.037、0.036和0.018)。
  • Ki-67阳性癌ΔADC大于Ki-67阴性癌(FDR校正P=0.018)。

诊断标准与关键数值

  • ADCshort和ADClong分别对应短和长扩散时间(4.7和96.6毫秒)的ADC值,ΔADC为ADC值随扩散时间的变化率。
  • ADC0-1000为标准方案(b值0和1000 s/mm²)的ADC值。
  • ADC值及ΔADC鉴别良恶性乳腺肿瘤的敏感度87.2%-90.7%,特异度87.0%-95.7%。
  • BI-RADS标准阅片鉴别良恶性乳腺肿瘤的敏感度100%,特异度73.9%。

临床应用与阅片要点

  • 报告中应注明DWI的扩散时间,因为ADC值随扩散时间变化。
  • ΔADC可能有助于鉴别良恶性肿瘤,但敏感度低于BI-RADS标准阅片。
  • ADC值与激素受体表达及Ki-67状态相关,尤其Ki-67阳性癌ΔADC更大。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: The aim of this study was to investigate the variation of apparent diffusion coefficient (ADC) values with diffusion time according to breast tumor type and prognostic biomarkers expression.

MATERIALS AND METHODS: A total of 201 patients with known or suspected breast tumors were prospectively enrolled in this study, and 132 breast tumors (86 malignant and 46 benign) were analyzed. Diffusion-weighted imaging scans with 2 diffusion times were acquired on a clinical 3-T magnetic resonance imaging scanner using oscillating and pulsed diffusion-encoding gradients (effective diffusion times, 4.7 and 96.6 milliseconds) and b values of 0 and 700 s/mm2. Diagnostic performances to differentiate malignant and benign breast tumors for ADC values at short and long diffusion times (ADCshort and ADClong), ΔADC (the rate of change in ADC values with diffusion time), ADC0-1000 (ADC value from a standard protocol), and standard reading including dynamic contrast-enhanced magnetic resonance imaging (BI-RADS) were investigated. The correlations of ADCshort, ADClong, and ΔADC values with hormone receptor expression and breast cancer subtypes were also analyzed.

RESULTS: The ADC values were lower, and ΔADC was higher in malignant tumors compared with benign tumors. The specificity of ADC values at all diffusion times and ΔADC values for differentiating malignant and benign breast tumors was superior to that of BI-RADS (87.0%-95.7% vs 73.9%), whereas the sensitivity was inferior (87.2%-90.7% vs 100%). Lower ADCshort and ADC0-1000 in ER-positive compared with ER-negative cancers (false discovery rate [FDR]-adjusted P = 0.037 and 0.018, respectively) and lower ADCshort, ADClong, and ADC0-1000 in progesterone receptor-positive compared with progesterone receptor-negative cancers (FDR-adjusted P = 0.037, 0.036, and 0.018, respectively) were found. Ki-67-positive cancers had larger ΔADCs than Ki-67-negative cancers (FDR-adjusted P = 0.018).

CONCLUSIONS: The ADC values vary with different diffusion time and vary in correlation with molecular biomarkers, especially Ki-67. Those results suggest that the diffusion time, which should be reported, might be a useful parameter to consider for breast cancer management.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Iima M, Kataoka M, Honda M, et al. The Rate of Apparent Diffusion Coefficient Change With Diffusion Time on Breast Diffusion-Weighted Imaging Depends on Breast Tumor Types and Molecular Prognostic Biomarker Expression. Invest Radiol. 2021. PMID: 33660629. doi:10.1097/RLI.0000000000000766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。